CORRELATION OF GENOMIC ANALYSIS BY MYAML™ WITH IN VITRO HIGH THROUGHPUT DRUG SENSITIVITY TESTING IN NEW DIAGNOSIS AND RELAPSED ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Becker, P. S. [1 ,2 ]
Schmitt, M. [3 ]
Loeb, L. [4 ]
Gu, W. [5 ]
Wei, Q. [5 ]
Xie, Z. [6 ]
Carson, A. [6 ]
Martins, T. [7 ]
Blau, C. A. [7 ,8 ]
Oehler, V. [2 ]
Yeung, K. Y. [9 ]
机构：
[1] Univ Washington, Div Hematol, Seattle, WA 98195 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98195 USA
[3] Univ Washington, Hematol & Med Oncol, Seattle, WA 98195 USA
[4] Univ Washington, Pathol, Seattle, WA 98195 USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Invivoscribe, San Diego, CA USA
[7] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA
[8] Univ Washington, Ctr Canc Innovat, Seattle, WA 98195 USA
[9] Univ Washington, Inst Technol, Tacoma, WA USA
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E919
引用
收藏
页码：365 / 366
页数：2
相关论文
共 50 条
  • [1] Toward Individualized Therapy: Correlation of Mutation Analysis with in Vitro high Throughput Drug Sensitivity Testing in New Diagnosis and Relapsed Acute Myeloid Leukemia
    Becker, Pamela S.
    Schmitt, Michael W.
    Xie, Zhiyi
    Carson, Andrew R.
    Patay, Bradley
    Khankhajeh, Seyed Sina
    Wei, Qi
    Hung, Ling-Hong
    Martins, Timothy
    Estey, Elihu H.
    Blau, C. Anthony
    Oehler, Vivian G.
    Yeung, Ka Yee
    BLOOD, 2015, 126 (23)
  • [2] Correlation of genomic analysis by MyAML with chemotherapy drug sensitivity.
    Becker, Pamela S.
    Schmitt, Michael W.
    Loeb, Lawrence A.
    Gu, Weiyi
    Wei, Qi
    Xie, Zhiyi
    Carson, Andrew R.
    Martins, Timothy
    Blau, Carl Anthony
    Oehler, Vivian
    Yeung, Ka Yee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay
    Becker, Pamela S.
    Oehler, Vivian
    Estey, Elihu H.
    Martins, Timothy
    Perdue, Andrea
    David, Jodie
    Chien, Sylvia
    Hendrie, Paul C.
    Ostronoff, Fabiana
    Blau, C. Anthony
    BLOOD, 2014, 124 (21)
  • [4] Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia
    Lv, Wenxiu
    Chen, Tianping
    Wang, Shen
    Li, Chun
    Zhang, Bo
    Wang, Liang
    Xv, Fang
    Cao, Fang
    Wang, Jing
    Chen, Li
    Liao, Chenglin
    Li, Na
    Liu, Hongjun
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [5] Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
    P O Pietarinen
    T Pemovska
    M Kontro
    B Yadav
    J P Mpindi
    E I Andersson
    M M Majumder
    H Kuusanmäki
    P Koskenvesa
    O Kallioniemi
    K Wennerberg
    C A Heckman
    S Mustjoki
    K Porkka
    Blood Cancer Journal, 2015, 5 (5) : e309 - e309
  • [6] Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
    Pietarinen, P. O.
    Pemovska, T.
    Kontro, M.
    Yadav, B.
    Mpindi, J. P.
    Andersson, E. I.
    Majumder, M. M.
    Kuusanmaki, H.
    Koskenvesa, P.
    Kallioniemi, O.
    Wennerberg, K.
    Heckman, C. A.
    Mustjoki, S.
    Porkka, K.
    BLOOD CANCER JOURNAL, 2015, 5
  • [7] Drug Sensitivity Across Acute Myeloid Leukemia Subtypes Using an in Vitro Assay
    Schachter, Levanto
    Hutchins, Irene M.
    Waalen, Jill
    Burian, Carol
    Finlay, Darren
    Vuori, Kristiina
    Paternostro, Giovanni
    Xavier, Marin F.
    Costantini, Carrie L.
    Miller, William E.
    Andrey, Jeffrey
    Mason, James
    BLOOD, 2016, 128 (22)
  • [8] Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics
    Cai, Daxia
    Liang, Jiajian
    Cai, Xing-Dong
    Yang, Ying
    Liu, Gexiu
    Zhou, Fenling
    He, Dongmei
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (01) : 126 - +
  • [9] High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia
    Mabrey, Frances Linzee
    Chien, Sylvia S.
    Martins, Timothy S.
    Annis, James
    Sekizaki, Taylor S.
    Dai, Jin
    Beckman, Robert A.
    Loeb, Lawrence A.
    Carson, Andrew
    Patay, Bradley
    Blau, Carl Anthony
    Oehler, Vivian G.
    Celik, Safiye S.
    Lee, Su-In
    Monnat, Raymond J.
    Abkowitz, Janis L.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    Becker, Pamela S.
    BLOOD, 2018, 132
  • [10] High-throughput mutation analysis in acute myeloid leukemia (AML)
    Dunlap, J.
    Corless, C. L.
    Fleming, W. H.
    Braziel, R.
    Leeborg, N.
    Gatter, K.
    Loriaux, M.
    Kelemen, K.
    Kovacsovics, T.
    Fan, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345